BO
ABBV icon

BRR OpCo’s AbbVie ABBV Stock Holding History

BRR OpCo’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3.59M Buy
26,737
+7,691
+40% +$1.1M 0.44% 30
2022
Q2 		$2.92M Buy
19,046
+649
+4% +$99.2K 0.35% 30
2022
Q1 		$2.98M Sell
18,397
-1,698
-8% -$247K 0.32% 30
2021
Q4 		$2.72M Buy
20,095
+663
+3% +$78.3K 0.29% 34
2021
Q3 		$2.1M Buy
19,432
+683
+4% +$78K 0.24% 49
2021
Q2 		$2.11M Sell
18,749
-105
-0.6% -$11.8K 0.23% 49
2021
Q1 		$2.04M Sell
18,854
-686
-4% -$73.4K 0.24% 44
2020
Q4 		$2.09M Buy
19,540
+1,638
+9% +$157K 0.31% 37
2020
Q3 		$1.57M Sell
17,902
-137
-0.8% -$12.9K 0.26% 40
2020
Q2 		$1.77M Buy
18,039
+784
+5% +$69K 0.31% 31
2020
Q1 		$1.31M Buy
17,255
+1,213
+8% +$103K 0.25% 41
2019
Q4 		$1.42M Buy
16,042
+11,648
+265% +$967K 0.2% 49
2019
Q3 		$333K Buy
4,394
+203
+5% +$13.9K 0.05% 137
2019
Q2 		$305K Buy
4,191
+19
+0.5% +$1.49K 0.05% 143
2019
Q1 		$336K Buy
4,172
+804
+24% +$65.8K 0.06% 120
2018
Q4 		$311K Buy
3,368
+66
+2% +$5.8K 0.06% 74
2018
Q3 		$312K Sell
3,302
-345
-9% -$32.7K 0.06% 82
2018
Q2 		$338K Buy
3,647
+433
+13% +$42.3K 0.09% 70
2018
Q1 		$304K Buy
3,214
+538
+20% +$59.1K 0.08% 76
2017
Q4 		$259K Sell
2,676
-585
-18% -$55.1K 0.07% 81
2017
Q3 		$289K Buy
+3,261
New +$248K 0.09% 77
2013
Q3 		– Sell
-6,038
Closed -$250K – 88
2013
Q2 		$250K Buy
+6,038
New +$264K 0.12% 78

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BRR OpCo's ABBV Position: Q3 2022 in Review

BRR OpCo increased its AbbVie (ABBV) stake by 40% in Q3 2022, buying an estimated $1.1M and bringing the position to 26,737 shares worth $3.59M. The position accounts for 0.44% of the portfolio, ranked #30.

BRR OpCo first reported a position in ABBV in Q2 2013 and has held it in 22 quarters since. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • BRR OpCo held 26,737 shares of AbbVie worth $3.59M as of Q3 2022.
  • BRR OpCo bought 7,691 AbbVie shares in Q3 2022, an estimated $1.1M.
  • AbbVie made up 0.44% of BRR OpCo's portfolio in Q3 2022, its #30 holding.
  • BRR OpCo first reported a position in AbbVie in Q2 2013 and has held it in 22 quarters since.
  • 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on BRR OpCo's 13F filing for Q3 2022, filed 8 Nov 2022.